Seven-year surveillance of nosocomial invasive aspergillosis in a French University Hospital

Journal of Infection

Volumn 65, Issue 6, 2012, Pages 559-567

  Garnaud, Cécile ^a   Brenier Pinchart, Marie Pierre ^a,b   Thiebaut Bertrand, Anne ^a   Hamidfar, Rebecca ^a   Quesada, Jean Louis ^a   Bosseray, Annick ^a   Lebeau, Bernadette ^a   Mallaret, Marie Reine ^a,b   Maubon, Danièle ^a,b   Saint Raymond, Christel ^a   Pinel, Claudine ^a,b   Hincky, Virginie ^a   Plantaz, Dominique ^a,b   Cornet, Muriel ^a,b   Pelloux, Hervé ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIV GRENOBLE ALPES   (France)

Author keywords

Construction works; Epidemiology; Invasive aspergillosis; Nosocomial infection; Outcome

Indexed keywords

VORICONAZOLE;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; DISEASE SURVEILLANCE; DRUG EFFECT; ENVIRONMENTAL PROTECTION; FEMALE; FRANCE; FUNGAL CONTAMINATION; HEMATOLOGIC MALIGNANCY; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INVASIVE ASPERGILLOSIS; LAMINAR AIRFLOW; MALE; OVERALL SURVIVAL; SURVIVAL RATE; TREATMENT DURATION; TREND STUDY; UNIVERSITY HOSPITAL;

ADULT; AGED; ASPERGILLOSIS; CROSS INFECTION; FEMALE; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PUBLIC HEALTH SURVEILLANCE; RISK FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84869089966     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.08.006     Document Type: Article

References (38)

1. Lortholary O., Gangneux J., Sitbon K., Lebeau B., de Monbrison Y., Le Strat B., et al. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007). Clin Microbiol Infect 2011, 17:1882-1889.
2. Baddley J.W. Clinical risk factors for invasive aspergillosis. Med Mycol 2011, 1:S7-S12.
3. Tsiodras S., Samonis G., Boumpas D.T., Kontoyiannis D.P. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 2008, 83:181-194.
4. Meersseman W., Van Wijngaerden E. Invasive aspergillosis in the ICU: an emerging disease. Intensive Care Med 2007, 33:1679-1681.
5. Guinea J., Torres-Narbona M., Gijón P., Muñoz P., Pozo F., Peláez T., et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 2010, 16:870-877.
6. Warris A., Verweij P.E. Clinical implications of environmental sources for Aspergillus. Med Mycol 2005, 1:S59-S65.
7. Brenier-Pinchart M.P., Lebeau B., Quesada J.L., Mallaret M.R., Borel J.L., Mollard A., et al. Influence of internal and outdoor factors on filamentous fungal flora in hematology wards. Am J Infect Control 2009, 37:631-637.
8. Lee L.D., Hachem R.Y., Berkheiser M., Hackett B., Jiang Y., Raad I.I. Hospital environment and invasive aspergillosis in patients with hematologic malignancy. Am J Infect Control 2011, 40:247-249.
9. Brenier-Pinchart M.P., Lebeau B., Borel J.L., Quesada J.L., Mallaret M.R., Garban F., et al. Community-acquired invasive aspergillosis and outdoor filamentous fungal spore load: a relationship?. Clin Microbiol Infect 2011, 17:1387-1390.
10. Pini G., Faggi E., Donato R., Sacco C., Fanci R. Invasive pulmonary aspergillosis in neutropenic patients and the influence of hospital renovation. Mycoses 2008, 51:117-122.
11. Arnow P.M., Andersen R.L., Mainous P.D., Smith E.J. Pulmonary aspergillosis during hospital renovation. Am Rev Respir Dis 1978, 118:49-53.
12. Gangneux J.P., Bretagne S., Cordonnier C., Datry A., Derouin F., Grillot R., et al. Prevention of nosocomial fungal infection: the French approach. Clin Infect Dis 2002, 35:343-346.
13. Chang C.C., Cheng A.C., Devitt B., Hughes A.J., Campbell P., Styles K., et al. Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works. J Hosp Infect 2008, 69:33-38.
14. Abdul S., Karlin R., Ling M., Yang K. The impact of portable high-efficiency particulate air filters on the incidence of invasive aspergillosis in a large acute tertiary-care hospital. Am J Infect Control 2010, 38:e1-e7.
15. Humphreys H. Positive-pressure isolation and the prevention of invasive aspergillosis. What is the evidence?. J Hosp Infect 2004, 56:93-100.
16. Sixt N., Dalle F., Lafon I., Aho S., Couillault G., Valot S., et al. Reduced fungal contamination of the indoor environment with the Plasmair system (Airinspace). J Hosp Infect 2007, 65:156-162.
17. Hahn T., Cummings K.M., Michalek A.M., Lipman B.J., Segal B.H., McCarthy P.L. Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies. Infect Control Hosp Epidemiol 2002, 23:525-531.
18. Cornet M., Levy V., Fleury L., Lortholary J., Barquins S., Coureul M.H., et al. Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation. Infect Control Hosp Epidemiol 1999, 20:508-513.
19. Haiduven D. Nosocomial aspergillosis and building construction. Med Mycol 2009, 1:S210-S216.
20. Lai K.K. A cluster of invasive aspergillosis in a bone marrow transplant unit related to construction and the utility of air sampling. Am J Infect Control 2001, 29:333-337.
21. Tablan O.C., Anderson L.J., Besser R., Bridges C., Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004, 53:1-36.
22. Consensus conference: preventing the risk of Aspergillus infection in immunocompromised patients. Bull Cancer 2001, 88:589-600.
23. Etancelin P., Silly S., Merle V., Bonmarchand G., Richard J.C., Vannier J.P., et al. Efficacy of a multidisciplinary team for preventing hospital-acquired invasive aspergillosis: five years' experience. Pathol Biol (Paris) 2009, 57:71-75.
24. Ruiz-Camps I., Aguado J.M., Almirante B., Bouza E., Ferrer-Barbera C.F., Len O., et al. Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Clin Microbiol Infect 2011, 2:1-24.
25. Fourneret-Vivier A., Lebeau B., Mallaret M.R., Brenier-Pinchart M.P., Brion J.P., Pinel C., et al. Hospital-wide prospective mandatory surveillance of invasive aspergillosis in a French teaching hospital (2000-2002). J Hosp Infect 2006, 62:22-28.
26. Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., Crokaert F., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7-14.
27. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
28. Graf K., Khani S.M., Ott E., Mattner F., Gastmeier P., Sohr D., et al. Five-years surveillance of invasive aspergillosis in a university hospital. BMC Infect Dis 2011, 11:163.
29. Fournel I., Sautour M., Lafon I., Sixt N., L'Ollivier C., Dalle F., et al. Airborne Aspergillus contamination during hospital construction works: efficacy of protective measures. Am J Infect Control 2010, 38:189-194.
30. Bénet T., Nicolle M.C., Thiebaut A., Piens M.A., Nicolini F.E., Thomas X., et al. Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure. Clin Infect Dis 2007, 45:682-686.
31. Warris A., Klaassen C., Meis J., De R., De V., Abrahamsen T., et al. Molecular epidemiology of Aspergillus fumigatus isolates recovered from water, air, and patients shows two clusters of genetically distinct strains. J Clin Microbiol 2003, 41:4101-4106.
32. Kauffmann-Lacroix C., Bousseau A., Dalle F., Brenier-Pinchart M., Delhaes L., Machouart M., et al. Prevention of fungal infections related to the water supply in French hospitals: proposal for standardization of methods. Presse Med 2008, 37:751-759.
33. Nicolle M.C., Benet T., Vanhems P. Aspergillosis: nosocomial or community-acquired?. Med Mycol 2011, 1:S24-S29.
34. Leenders A.C., van Belkum A., Behrendt M., Luijendijk A., Verbrugh H. Density and molecular epidemiology of Aspergillus in air and relationship to outbreaks of Aspergillus infection. J Clin Microbiol 1999, 37:1752-1757.
35. Diaz-Guerra T.M., Mellado E., Cuenca-Estrella M., Gaztelurrutia L., Navarro J.I., Tudela J.L. Genetic similarity among one Aspergillus flavus strain isolated from a patient who underwent heart surgery and two environmental strains obtained from the operating room. J Clin Microbiol 2000, 38:2419-2422.
36. Partridge-Hinckley K., Liddell G.M., Almyroudis N.G., Segal B.H. Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients. Mycopathologia 2009, 168:329-337.
37. Walsh T., Anaissie E., Denning D., Herbrecht R., Kontoyiannis D., Marr K., et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious diseases Society of America. Clin Infect Dis 2008, 46:327-360.
38. Tsitsikas D.A., Morin A., Araf S., Murtagh B., Johnson G., Vinnicombe S., et al. Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis. Med Mycol 2011, 1-5.